Cite

HARVARD Citation

    Orak, B. et al. (2021). SIGLEC1 (CD169) as a potential diagnostical screening marker for monogenic interferonopathies. Pediatric allergy and immunology. 32 (3), pp. 621-625. [Online]. 
  
Back to record